+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 163 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5821005
The publisher's Medical Devices sector report, 'Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators (DBS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
2 Introduction
2.1 Deep Brain Stimulators (DBS) Overview
3 Products under Development
3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies
4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
5 Deep Brain Stimulators (DBS) Companies and Product Overview6 Deep Brain Stimulators (DBS)- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
  • Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Actipulse Neuroscience Inc
  • Adaptive Neuromodulation GmbH
  • Adept Neuro SA
  • Aleva Neurotherapeutics SA
  • Allegheny Health Network
  • Baylor College of Medicine
  • Bioinduction Limited
  • Boston Scientific Corp
  • Brainsway Ltd
  • ClearPoint Medical
  • ClearPoint Neuro Inc
  • Cleveland Medical Devices Inc
  • Clinatec
  • Deep Brain Innovations, LLC
  • Deep Brain Stimulation Technologies Pty Ltd
  • Endonovo Therapeutics Inc
  • Enspire DBS Therapy Inc
  • Functional Neuromodulation Inc.
  • Hangzhou General Stim Biotechnology Co Ltd
  • Louisiana State University
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • Medtronic Neuromodulation
  • Medtronic Plc
  • National Cheng-Kung University Hospital
  • Neurode Pty Ltd
  • NeuroOne Medical Technologies Corp
  • Neuroparticle Corp
  • NeuroPro Technologies Inc
  • Neurosigma Inc
  • Newronika s.r.l.
  • Nexeon MedSystems Inc
  • Nia Therapeutics Inc
  • Onward Technologies Ltd
  • Oxford University Innovation Ltd
  • Salvia Bioelectronics BV
  • Soterix Medical Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • Sunnybrook Health Sciences Centre
  • SUNY Downstate Medical Center
  • The Magstim Co Ltd
  • University of California Los Angeles
  • University of California San Francisco
  • University of Central Florida
  • University of Florida
  • University of Houston
  • University of Illinois
  • University of Milan
  • University of Minnesota
  • University of Oxford
  • University of Queensland
  • University of Rochester
  • University of South Florida
  • Wedge Therapeutics